New project aims to tackle stigma of substance use disorders in patients seeking HIV care – School of Medicine News

An interdisciplinary and interprofessional team of professors from three departments at Wayne State University School of Medicine has initiated a three-year project to plan a multi-level intervention to reduce the stigma of substance use disorders in patients receiving HIV care.

Erin Fanning Madden, Ph.D., MPH, is the Principal Investigator on “Planning a Multi-Level Intervention to Reduce Substance Use Stigma in HIV Prevention and Care,” funded by a three-year grant of $ 684,027 launched September 30 the National Institute for Drug Abuse Control.

Erin Madden, Ph.D., MPH

She is an Assistant Professor in the Department of Family Medicine and Public Health Sciences. The co-principal investigator of the study is Mark Greenwald, Ph.D., Gertrude Levin Chair in Addiction and Pain Biology and Professor of Psychiatry and Behavioral Neuroscience. Dr Greenwald also heads the Department’s Substance Abuse Research Division.

Co-investigators include the Department of Internal Medicine, Division of Infectious Diseases; Professor Jonathan Cohn, MD, a renowned expert in HIV care; and Fares Qeadan, MS, associate professor of biostatistics at Loyola University in Chicago.

The project will use a community-based research approach to plan a trial with federally accredited health centers.

“Although it is well known that people living with HIV and people who use substances are stigmatized and that this stigma negatively affects access and quality of health care, research on how to reduce stigma is extremely limited, ”said Dr. Madden. “Most studies of interventions to reduce stigma among health care providers focus exclusively on training and only measure short-term attitude changes. Our team will use this planning grant to work with professionals providing care in metro Detroit communities to plan a feasible and rigorous test of an intervention that combines education and changes to organizational factors that can foster stigma in health care facilities.

The planning process will allow researchers to design a trial that measures attitude change among providers and clinic staff, as well as changes in patient outcomes and objective measures of service delivery.

“Our goal is to tailor and refine a multi-level intervention on substance use stigma that leverages education and organizational policy to address structural factors of stigma and attitudes and stigmatizing professional behaviors that affect patients, ”said Dr. Madden. “Further results of experimental research should provide scientific evidence demonstrating how healthcare organizations can address the stigma associated with substance use that influences HIV prevention and care outcomes among people who use drugs. drugs. “

The study team aims to identify eight primary care sites in the Detroit metro area that agree to collaborate in planning an intervention trial. They will also pilot stigma training for clinical and administrative staff; identify site policy changes that may reduce organizational factors of substance use stigma; and collaboratively plan a trial study that would test the effect of training and policy changes on stigma among primary care professionals and other clinic staff.

At the end of the three-year planning grant, the team will apply for additional funding to conduct the stigma intervention trial with the eight sites.

The grant number for this study from the National Institutes of Health is R34DA053758.

Source link

About Bradley J. Bridges

Check Also

HIV Associated Lipodystrophy Syndrome Treatment Market Size, Trends 2021, Growth, Share, Trends and Forecast to 2028

New Jersey, United States, – Global HIV Associated Lipodystrophy Syndrome Treatment market comprises market share, …